We are live on ! Find out more
PCM

Pavaki Capital Management Portfolio holdings

AUM $287M
This Fund
S&P 500
This Quarter Est. Return
+0.76%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$235M
AUM Growth
-$19.8M
Cap. Flow
+$10.3M
Cap. Flow %
4.36%
Top 10 Hldgs %
50.47%
Holding
162
New
31
Increased
16
Reduced
7
Closed
6

Top Buys

Rank Stock Value
1
CVX icon
Chevron
CVX
+$13.2M
2
EWS icon
iShares MSCI Singapore ETF
EWS
+$1.69M
3
ESPR
Esperion Therapeutics
ESPR
+$1.3M
4
B
Barrick Mining
B
+$1.27M
5
NAMS icon
NewAmsterdam Pharma
NAMS
+$1.19M

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$8.8M
2
SPRY icon
ARS Pharmaceuticals
SPRY
+$5.71M
3
OGN icon
Organon & Co
OGN
+$3.01M
4
ROIV icon
Roivant Sciences
ROIV
+$868K
5
ALT icon
Altimmune
ALT
+$778K

Sector Composition

Rank Sector Weight
1 Miscellaneous 41.44%
2 Healthcare 20.32%
3 Materials 13.21%
4 Energy 8.84%
5 Technology 4.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PFE icon
101
Pfizer
PFE
$164B
$348K 0.15%
12,400
– –
UAE icon
102
iShares MSCI UAE ETF
UAE
$316M
$336K 0.14%
+18,000
New +$360K
IAG icon
103
IAMGOLD
IAG
$10.6B
$316K 0.13%
16,800
– –
BKR icon
104
Baker Hughes
BKR
$55.5B
$305K 0.13%
+5,000
New +$289K
QQQE icon
105
PUT
Direxion NASDAQ-100 Equal Weighted Index ETF
QQQE
$1.41B
$296K 0.13%
3,000
– –
DNOW icon
106
DNOW Inc
DNOW
$2.84B
$292K 0.12%
+24,500
New +$332K
BEN icon
107
Franklin Templeton
BEN
$16.6B
$283K 0.12%
12,000
– –
SHEL icon
108
Shell
SHEL
$271B
$279K 0.12%
3,000
– –
ORLY icon
109
PUT
O'Reilly Automotive
ORLY
$69.6B
$277K 0.12%
3,000
-14,600
-83% -$1.37M
FONR
110
DELISTED
Fonar
FONR
$275K 0.12%
+14,796
New +$275K
ARKF icon
111
PUT
ARK Blockchain & Fintech Innovation ETF
ARKF
$842M
$266K 0.11%
7,000
– –
PLD icon
112
CALL
Prologis
PLD
$126B
$264K 0.11%
2,000
– –
TSN icon
113
Tyson Foods
TSN
$17.9B
$256K 0.11%
4,000
– –
KURA icon
114
Kura Oncology
KURA
$961M
$244K 0.1%
30,000
– –
NRP icon
115
Natural Resource Partners
NRP
$1.46B
$242K 0.1%
+2,000
New +$237K
HYG icon
116
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.3B
$239K 0.1%
3,000
– –
CRSP icon
117
CRISPR Therapeutics
CRSP
$5.41B
$238K 0.1%
+5,000
New +$264K
BP icon
118
BP
BP
$112B
$235K 0.1%
5,000
– –
JOUT icon
119
Johnson Outdoors
JOUT
$464M
$233K 0.1%
5,000
– –
GLRE icon
120
Greenlight Captial
GLRE
$481M
$225K 0.1%
13,000
– –
FAF icon
121
First American
FAF
$6.54B
$223K 0.09%
3,700
– –
GMAB icon
122
Genmab
GMAB
$22.2B
$215K 0.09%
+8,000
New +$240K
CPRX
123
DELISTED
Catalyst Pharmaceutical
CPRX
$198K 0.08%
8,000
– –
PSI icon
124
PUT
Invesco Semiconductors ETF
PSI
$2.87B
$189K 0.08%
2,000
– –
NVGS icon
125
Navigator Holdings
NVGS
$1.41B
$174K 0.07%
9,000
– –
3 4
5
6 7

Similar funds

OCM
Ogborne Capital Management San Francisco, California $287M AUM 14.05% 1-Year Est. Return
RSC
Red Spruce Capital Berwyn, Pennsylvania $287M AUM 38.81% 1-Year Est. Return
MC
Metavasi Capital Larchmont, New York $287M AUM 97.9% 1-Year Est. Return
QFW
QTR Family Wealth Lake Mary, Florida $287M AUM 40.55% 1-Year Est. Return
SRWM
Shira Ridge Wealth Management Larkspur, California $287M AUM 23.34% 1-Year Est. Return
ORC
O'Rourke & Company Boston, Massachusetts $287M AUM 23.01% 1-Year Est. Return
MPAM
Murphy Pohlad Asset Management Eden Prairie, Minnesota $287M AUM 38.81% 1-Year Est. Return
AWMT
AAFMAA Wealth Management & Trust Fayetteville, North Carolina $286M AUM 19.57% 1-Year Est. Return

Pavaki Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Pavaki Capital Management held 162 positions worth $235M, down 7.8% from $255M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Pavaki Capital Management deployed $10.3M of net new capital in Q1 2026, opening 31 new positions and adding to 16 existing holdings. Its largest new stake was iShares MSCI Singapore ETF: 60,000 shares worth $1.69M.

By sector, the portfolio is most concentrated in Miscellaneous at 41% of assets, down from 44% a quarter earlier, followed by Healthcare and Materials.

On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $8.8M trimmed.

  • Pavaki Capital Management's largest Q1 2026 buy was iShares MSCI Singapore ETF: 60,000 shares worth $1.69M.
  • Pavaki Capital Management added most to Chevron in Q1 2026, an estimated $13.2M increase.
  • Pavaki Capital Management's biggest Q1 2026 reduction was Regeneron Pharmaceuticals, cutting an estimated $8.8M.
  • Pavaki Capital Management fully exited Roivant Sciences in Q1 2026, selling an estimated $868K.
  • Pavaki Capital Management's ten largest holdings make up 50% of its $235M portfolio in Q1 2026.
  • Pavaki Capital Management opened 31 new positions and closed 6 in Q1 2026.
  • Pavaki Capital Management's portfolio value fell 7.8% quarter-over-quarter to $235M.

Based on Pavaki Capital Management's 13F filing for Q1 2026, filed 7 Aug 2026.